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Abstract
Ribosome is responsible for protein synthesis in all organisms and ribosomal proteins (RPs) play important roles in the
formation of a functional ribosome. L11 was recently shown to regulate p53 activity through a direct binding with MDM2
and abrogating the MDM2-induced p53 degradation in response to ribosomal stress. However, the studies were performed
in cell lines and the significance of this tumor suppressor function of L11 has yet to be explored in animal models. To
investigate the effects of the deletion of L11 and its physiological relevance to p53 activity, we knocked down the rpl11
gene in zebrafish and analyzed the p53 response. Contrary to the cell line-based results, our data indicate that an L11
deficiency in a model organism activates the p53 pathway. The L11-deficient embryos (morphants) displayed
developmental abnormalities primarily in the brain, leading to embryonic lethality within 6–7 days post fertilization.
Extensive apoptosis was observed in the head region of the morphants, thus correlating the morphological defects with
apparent cell death. A decrease in total abundance of genes involved in neural patterning of the brain was observed in the
morphants, suggesting a reduction in neural progenitor cells. Upregulation of the genes involved in the p53 pathway were
observed in the morphants. Simultaneous knockdown of the p53 gene rescued the developmental defects and apoptosis in
the morphants. These results suggest that ribosomal dysfunction due to the loss of L11 activates a p53-dependent
checkpoint response to prevent improper embryonic development.
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Introduction
The ribosome is an essential complex macromolecule responsible
for protein synthesis in all organisms. In eukaryotes, a mature
ribosome consists of 79 RPs and four rRNA species [1,2]. RPs are
important in the formation of a fully functional ribosome because
they facilitate specific rRNA conformational changes during the
assemblyof theribosomalsubunits [3].Besidestheirroleinribosome
biogenesis, many RPs are believed to have important functions in
various other cellular processes [4,5]. Although recent high
resolution crystallography results have demonstrated the structure
of various RPs and their interaction with rRNAs in the ribosome
[6,7], such specific functions of RPs have yet to be investigated.
Haploinsufficiency of RPs in Drosophila leads to the Minute
mutants, relatively normal flies with short thin bristles and delayed
development [8,9]. Such phenotypes are believed to be due to a
reduced protein synthesis capacity of their ribosomes. However,
recent reports indicate that mutations in RPs in vertebrates lead to
specific phenotypes that are unlike the nonspecific general
phenotypes typically expected for housekeeping genes. For
example, a mutation in Rpl24 in mice results in the ‘Belly spot
and tail’ (Bst) mutant, which displays a kinked tail, a white ventral
midline spot, and other skeletal deformities [10]. In zebrafish,
malignant peripheral nerve sheath tumors (MPNSTs) are
associated with haploinsufficiency of 11 RP genes, suggesting a
role for RPs in tumorigenesis [11]. RP mutations have been
observed in human diseases as well. Four RP genes, RPS19 RPS24,
RPS17, and RPL35a [12–15] are known to be mutated in
Diamond-Blackfan anemia (DBA; MIM 105650), a congenital
erthyroid aplasia characterized by macrocytic anemia. RPS14 has
been implicated as the responsible gene in 5q
2 syndrome, a
disease that leads to a severe decrease in erythrocyte numbers in
the bone marrow, resulting in a macrocytic anemia similar to DBA
[16]. Our previous systematic knockdown analyses of RP genes in
zebrafish produced gene-specific phenotypes that depended on the
RP gene targeted [17,18]. Thus, many RPs may have distinct
functions, besides their involvement in ribosome formation, which
are currently unknown. Investigating these unknown functions of
RPs using animal models is vital for understanding the role of
ribosomal proteins in human diseases.
L11 is one such RP proposed to have a dual physiological role;
it is thought to participate in ribosomal assembly and in regulation
of p53 activity [19]. Studies in human cell lines have demonstrated
that L11 binds to MDM2, prevents MDM2-mediated p53
ubiquitination and degradation, stabilizes and activates p53, and
induces cell cycle arrest [19,20]. Overexpression of L11 or
actinomycin D-induced ribosomal stress increases this L11-
MDM2 interaction and subsequent p53 stabilization [21].
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tumorigenesis; loss of p53 function is associated with the majority
of human cancers. Activation of p53 induces cell cycle arrest,
apoptosis, or DNA repair when cells are damaged or stressed [22].
Because of its inhibitory effects on cell growth, p53 is maintained
at a low steady-state level in normal conditions by its negative
regulator, MDM2, through ubiquitin-dependent p53 degradation
[23]. Recent findings indicate that alterations in ribosome
biogenesis are linked to the p53 pathway. Various studies have
demonstrated that mutations in nucleolar proteins involved in
rRNA synthesis or ribosomal subunit assembly affect ribosome
synthesis and activate a p53 response through a nucleolus
mediated stress [24–26]. Nucleolus is the major site of ribosome
production [27] and it has been shown that disruption of the
nucleolus is required for p53 activation and stabilization [28].
We report here that a deficiency in L11 activates the p53
pathway, and absence of L11 disrupts the normal embryonic
development of zebrafish, presumably through a p53-mediated
apoptotic response.
Results
Knockdown of rpl11 leads to morphological defects
mainly in the developing brain
Zebrafish L11 shares 95% amino acid identity with its human
ortholog.Wetargeted thisgeneusinganMorpholinoantisenseoligo
(MO) aimed at its translation initiation site. Based on our previous
data [17], we injected rpl11 MO and control MO (a five base
mismatch of rpl11 MO) at a predetermined concentration (50 pg/
embryo) into one-cell zebrafish embryos and analyzed the resulting
phenotypes. At 24 hours post-fertilization (hpf), the morphants
displayed an overall reduction of body length with an uncharac-
teristic cloudiness or opacity in the head region. However, the trunk
region appeared to be relatively normal (Figure 1A, left panel). We
also observed other phenotypes commonly associated with RP
morphants [17], such as hypoplasia of the yolk sac extension,
abnormalities in the ear, and delayed pigmentation of the eyes.
Close up examination of the brain revealed improper differentia-
tion, such as an enlarged forebrain, indistinct isthmic constriction at
the midbrain-hindbrain boundary (mhb), and a malformed
hindbrain (Figure 1A, right panel). The embryos injected with the
controlMOdidnotdisplayanysuchmutantphenotypes(Figure1A,
middle row). By 4 days post-fertilization (dpf), the head and the eyes
were significantly smaller in the morphants and the heart displayed
pericardial edema. Improper yolk consumption and absence of a
proper gut was also evident (Figure 1B). All the morphants died by
6–7 dpf. A reduction in the L11 protein level was confirmed using a
rabbit polyclonal antibody specific to human L11 [19]. At 24 hpf,
L11 was dramatically decreased in the rpl11 MO-injected embryos,
whereasinjectionofcontrolMOdidnotalterL11levels(Figure1C).
rpl11 deficiency associated morphological defects are
rescued by coinjection of rpl11 mRNA
Coinjection of MO-resistant rpl11 mRNA at 25 ng/ml (100 pl/
embryo), but not overexpression of GFP mRNA, rescued the
developmental defects in the morphants. This indicates that the
altered phenotypes in the morphants were specifically due to a loss
of L11. When observed at 24 hpf, the head region and the overall
body length were completely recovered in rpl11 mRNA-coinjected
embryos, whereas GFP mRNA-coinjected embryos still displayed
morphant phenotypes (Figure 2). Various parts of the brain, such
as the isthmus of the midbrain-hindbrain boundary, the forebrain,
and the hind brain, were rescued in rpl11 mRNA-coinjected
embryos (Figure 2, insets in the upper panel). By 3 dpf, the rescue
of the morphants was more evident (Figure 2, lower panel).
Neuronal cell abundance, but not fate, is affected by
rpl11 deficiency in the brain
Since the morphants displayed altered phenotypes mainly in the
brain region during early developmental stages (24 hpf), we
performed in situ hybridization to analyze the expression pattern
of several marker genes involved in neural patterning of the brain.
The expression of otx2, a mid brain marker, showed a decrease in
total abundance in the morphants, compared to the wild-type
embryos (Figure 3A). The expression of krox20, a marker specific for
hindbrain segmentation, was unaffected in the morphants
(Figure 3B), although they displayed a morphologically deformed
hindbrain. We also analyzed the expression pattern of shh,a
neuronal marker specific for the floor plate organizer (fp) and the
forebrain/midbrain boundary (fmb). The expression of shh at fp was
unaffected,butthe expression level atfmbwas marginallydecreased
in the morphants (Figure 3C, inset), indicating that decreased axis
length in the morphants is not due to the loss of floor plate
formation. However, the localization of these neural markers in the
morphants was same as that of wild-type embryos, suggesting that
Figure 1. L11 deficiency causes morphological defects in
zebrafish. (A) Lateral views of morphants (rpl11 MO, upper panel),
controls (control MO, middle panel), and wild-type embryos (WT, lower
panel) at 24 hpf. The morphants are smaller in size to the control
embryos and the yolk sac extension is incomplete (black solid line). The
right hand panel shows a close-up of the head region. The morphants
display deformities in various parts of the brain, such as the midbrain-
hindbrain boundary (filled black triangle), hindbrain (asterisk), and
otolith (arrow). (B) Morphological observation of morphants and wild-
type embryos at 4 dpf. The morphants have a smaller head and eyes,
severe edema of the heart (arrow, upper panel), and incomplete yolk
consumption with no gut (white solid line, upper panel) compared to
wild-type embryos. (C) Western blot analysis of L11 in the morphants
and control embryos with fibrillarin as a loading control. All images are
anterior to the left. Scale bars: A, 500 mm (left panel), 100 mm (right
panel); B, 500 mm. e, eye; g, gut.
doi:10.1371/journal.pone.0004152.g001
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deficiency, although results in neural cell death, does not change the
patterning and localization of the neural cells in the brain.
rpl11 deficiency leads to misregulated expression of
transcription factors
We investigated whether the defects in the brain could be due to
an aberrant expression of transcription factors that play important
role in vertebrate morphogenesis, particularly that of the brain.
Pax2 and pax6a, members of the paired box family of transcription
factors are important for the brain development in zebrafish. In situ
analysis of pax6a revealed a decrease in the total abundance
(reduction in staining intensity) in the forebrain region of the
morphants (Figure 3D). However, an overexpression of pax2
transcript was observed in the morphants at 24 hpf (Figure 3E).
Thus, it appears that the pax6a and pax2 signaling pathway is
affected by L11 deficiency, although the exact mechanism of such
an effect remains to be defined. Overexpression of pax2 has been
observed in zebrafish aussicht (aus) mutant, a dominant mutant
identified by ENU screening, which exhibit defects in the
differentiation of forebrain, midbrain and eyes [29]. This
corroborates our data that the specific defects in the brain
development, as seen in L11-deficient embryos, may lead to
aberrant expression of these markers. The analysis of the
expression pattern of these neural markers in control MO-injected
embryos revealed similar levels to those in wild-type embryos
(Figure S1), confirming that the decrease in abundance of these
neural marker genes were specific to l11 deficiency.
Developmental defects in L11-deficient embryos are due
to increased cellular apoptosis
To determine whether the developmental defects observed in
the morphants were due to apoptosis, we analyzed the morphants
and the control embryos using a TUNEL assay. Extensive
apoptosis, as indicated by increased numbers of TUNEL-positive
cells, were observed in the morphants at 24 hpf (Figure 4A and
4B). In contrast, the control MO-injected embryos and wild-type
embryos displayed only a few scattered apoptotic cells, at levels
consistent with previous observations [30]. Moreover, TUNEL-
positive cells in the morphants were concentrated in the head
regions (Figure 4A) that displayed morphological abnormalities
(Figure 1A, right panel).
p53 pathway is activated in L11-deficient embryos
To examine whether a p53-pathway was activated with the loss
of L11, we analyzed the expression of p53 and its target genes in
L11-deficient embryos. Semi-quantitative RT-PCR at 24 hpf
showed marked upregulation of p53 mRNA in the morphants
(Figure 4C). Upregulation of p21, an important kinase and a
transcriptional target of p53, and mdm2, the negative regulator and
downstream target of p53, was also seen in L11-deficient embryos
but not in control MO-injected and wild type embryos (Figure 4C).
The proapoptotic Bcl-2 family genes (bik, bax, noxa, and puma),
which are regulated by p53, showed transcriptional upregulation
in the morphants compared to the control embryos (Figure 4D),
whereas the prosurvival markers (blp1, mcl1a) were not altered in
the morphants, indicating an activated apoptotic pathway; this
result was consistent with the TUNEL data (Figure 4A). In order
to confirm that the increase in p53 activity was specifically due to
rpl11 knockdown, we analyzed the transcript levels of the kinase
atm, which is activated during DNA damage; gadd45a, a p53 target
gene activated during DNA damage; and the oncogenes myca and
nras. There was no difference in the transcript levels of these genes
between the morphants and the control embryos (Figure 4E),
suggesting that DNA damage or oncogene overexpression is not
responsible for p53 activation in L11-deficient embryos.
To determine whether p53 activation was an immediate effect
of L11 loss-of-function, we performed a time course analysis of p53
and its target genes in L11-deficient and wild-type embryos at
various stages post fertilization (4, 8, 12, and 48 hpf). Our data
indicate that activation of p53 and its target genes in L11-deficient
embryos coincided with the start of zygotic transcription during
embryogenesis (Figure S2). Zebrafish embryos do not begin
zygotic transcription until 3 hpf and early development proceeds
Figure 2. Morphological defects in L11-deficient embryos are rescued by rpl11 mRNA. (A) Morphology of L11-deficient embryos (24 hpf)
coinjected separately with rpl11 mRNA and GFP mRNA. rpl11 mRNA (25 ng/ml) coinjected with rpl11 MO (0.5 mg/ml) completely recovers the body
length in 24 hpf embryos, but GFP mRNA does not produce any recovery. Insets show the rescue of brain parts such as midbrain-hindbrain boundary
(arrow) in the embryos coinjected with rpl11mRNA, but not in GFP mRNA–coinjected embryos. (B) Morphological observation of the rpl11 mRNA and
GFP mRNA–coinjected embryos at 3 dpf. The rpl11 mRNA–coinjected embryos have proper head and eye phenotypes, similar to those of the wild-
type embryos, whereas GFP mRNA-coinjected embryos display smaller heads and eyes (black curved line) and pericardial edema (arrow). Scale bars:
A, inset, 100 mm; B, 500 mm.
doi:10.1371/journal.pone.0004152.g002
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after the start of zygotic transcription, there was no difference in
the transcript levels of p53 and its target genes between L11-
deficient and wild type embryos (Figure S2). However, by 8 hpf,
marginal upregulation of p53 and p21 transcripts were evident in
L11-deficient embryos. By 12 hpf, mdm2, bax, and puma also
showed transcriptional upregulation in the morphants. At 48 hpf,
p53 and its target genes were significantly upregulated in the L11-
deficient embryos (Figure S2).
Finally, to examine if the expression of p53 and its target genes is
localized specifically in the head region of the morphants, we
performed in situ hybridization of p53 and one of its target gene,
mdm2. L11-deficient embryos showed increased p53 expression,
almost exclusively in the head region, as compared to the wild-type
embryos (Figure 4F). Similarly, mdm2 expression, although more
ubiquitous than p53, was increased in the morphants particularly
in the head region (Figure 4F). These data indicates that p53
activation in the brain was consistent with the neural cell death
and increased apoptosis in the morphants.
Suppression of p53 activity rescues the developmental
defects and apoptosis in L11-deficient embryos
Since an L11 deficiency activates a p53-dependent apoptotic
response, we examined whether simultaneous knockdown of p53
and rpl11 could rescue the developmental defects and apoptosis of
L11-deficient embryos. A previous study has shown that 4 ng/
embryo of p53 MO specifically blocks the synthesis of the zebrafish
Figure 3. The L11-deficient embryos exhibit reduced abundance of neuronal progenitor cells and aberrant expression of
transcription factors. (A) Expression of otx2 at 24 hpf. The morphants show a reduction in total abundance of otx2, but its pattern of expression is
same as that of wild-type embryos. The inset shows the dorsal view of the midbrain region. (B) krox20 expression at the hindbrain in 24 hpf embryos.
The morphants show a proper hindbrain patterning compared to the wild-type embryos. (C) Expression of shh in morphants and wild-type embryos
at 24 hpf. The morphants show a marginal reduction in the forebrain midbrain boundary (fmb, inset in C), but floor plate (fp) expression is unaffected.
(D) Expression of pax6a in morphants and wild-type embryos at 24 hpf. The morphants show a reduction in total abundance of pax6a, but its pattern
of expression is same as that of wild-type embryos (E) The morphants show an increased level of pax2 expression compared to wild-type embryos.
The midbrain hindbrain boundary (mhb) expression of pax2 is short and wide in the morphants. pax2 expression at the optic stalk and the otic
capsules is also increased in the morphants. All images are in lateral views with anterior to the left. Scale bar: 250 mm. hb, hindbrain; dd; dorsal
diencephalon; t, telencephalon; r3, rhombomere 3; r5, rhombomere 5; fmb, forebrain-midbrain boundary; os, optic stalk; mhb, midbrain-hindbrain
boundary; oc, otic capsule; sn, spinal chord neurons.
doi:10.1371/journal.pone.0004152.g003
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simultaneous knockdown, we used 50 pg/embryo of p53 MO,
which was sufficient to perfectly suppress p53 activity (Figure S3).
We coinjected rpl11 MO and p53 MO, or their respective control
MOs, into zebrafish at the one-cell stage, and analyzed the
resulting phenotypes. Coinjection of rpl11 MO and p53 MO
could rescue the developmental defects, but p53 misMO-
coinjected embryos displayed the same developmental defects as
those in L11-deficient embryos (Figure 5A). The mhb and the
enlarged forebrain were rescued in rpl11 MO/p53 MO-coinjected
embryos but not in p53 misMO-coinjected embryos (Figure 5B).
To assessthenumberofapoptoticcellsinthecoinjected embryos,
we performed a TUNEL assay. As expected, coinjection of rpl11
MO and p53 MO resulted in a substantial reduction of TUNEL-
positive cells, to levels nearly the same as those in wild-type embryos
(Figure 5C and D). Although the p53 MO-injected rpl11 morphants
survived longerthan theembryos injected withonly rpl11 MO,they
eventually died between 9 and 10 dpf (data not shown). Thus, the
loss of p53 function leads to suppression of early apoptosis and
developmental defects in L11-deficient embryos, but fails to rescue
the ribosomal dysfunction that is associated with L11 deficiency.
These results indicate that a p53-mediated apoptotic response is
activated upon rpl11 knockdown in zebrafish.
Discussion
In recent years, three RPs, L5, L11, and L23, have been shown
to regulate p53 activity by binding to MDM2 specifically in
response to a ribosomal stress [19,32,33] which has led to
speculations about a novel ribosome-mediated p53 checkpoint
mechanism. Of these three RPs, L11 has been the most extensively
studied for its role in the MDM2-p53 pathway. Previous reports
have shown that overexpression of L11 in ribosome-perturbed
cells, but not in DNA-damaged or oncogene-activated cells,
greatly increases L11-MDM2 binding in a p53-dependent manner
both in normal and in tumor cells [19,34]. Moreover, the direct
binding of L11 (central domain, amino acids 51–108) is essential
for MDM2 stabilization [35]. Taken together, these results
Figure 4. L11 deficiency results in increased cellular apoptosis mediated by p53. (A) TUNEL staining at 24 hpf. The morphants show
massive apoptosis (blue dots indicate the TUNEL-positive cells) concentrated primarily in the head region compared to a few scattered positive cells
in control and wild-type embryos. (B) Histogram showing the number of apoptotic cells in the head region. Values represent the mean of total
number of apoptotic cells counted in the head region of three embryos each for the morphant, control, and wild-type embryos. (C-E) Semi-
quantitative RT-PCR of p53, p53-target genes, Bcl-2 family genes, atm, gadd45a, myca, and nras transcript levels relative to actin in the morphant,
control, and wild-type embryos at 24 hpf. (F) In situ analysis of p53 and mdm2 at 24 hpf. The morphants show increased expression of p53, exclusively
in the head region. mdm2 expression, although more ubiquitous, is also increased in the morphants, particularly in the head region. All images are in
lateral views with anterior to the top in A and left in F. Scale bars: A, 500 mm.
doi:10.1371/journal.pone.0004152.g004
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loop in response to ribosome stress.
To understand the importance of this association in a model
system like zebrafish, we reduced the level of L11 protein by a
knockdown strategy and analyzed the phenotypes. The MO used
in this study was designed to target the initiation codon of rpl11
mRNA so that the synthesis of the entire protein was blocked.
Since L11 is required for ribosome assembly, knocking down this
protein should result in a ribosomal stress. And as the association
of L11-MDM2 greatly increases in response to ribosomal stress, it
is expected that removal of L11 in a system without DNA damage
or oncogenic overexpression should result in reduced L11-MDM2
binding or increased MDM2-p53 binding.
Contrary to expectations, our data show that an L11 deficiency
activates the p53 pathway leading to developmental abnormalities,
apoptosis, and embryonic lethality. Interference with ribosomal
biogenesis by actinomycin D further increased the level of
apoptosis in L11-deficient embryos (data not shown), as ribosomal
biogenesis was already compromised in these embryos.
We have clearly shown that this p53 activation and the associated
neural cell death in rpl11 MO-injected embryos is not an off-target
effect of morpholino [36] but a result of specific loss of L11 protein.
First, our morphants were phenotypically similar (Figure S4) to a
zebrafish mutant line having a viral insert in the rpl11 gene
(rpl11
hi3820btg). This mutant was identified in a forward genetic screen
for essential genes [37]. Second, we have verified the loss of L11
proteinbyusing a humanL11 antibody. Third,the phenotype of the
L11 morphants was completely rescued by MO resistant rpL11
mRNA (Figure 2). Fourth, upregulation of p53 response in other RP
mutants [38] and ribosome-associatedproteinmutants[39]validates
our data that p53 activation in L11-deficient embryos is not due to
non-specific morpholino response but due to the specific loss of L11
protein. Finally, the control morpholino, which is a five base
mismatch of the original MO, did not result in any phenotype,
apoptosis or upregulation of the p53 pathway (Figure 1A, Figure 4).
It can be argued that L5 and L23, which also have MDM2
binding properties, may be responsible for the observed increased
p53 activity in L11-deficient embryos. In the absence of proper
Figure 5. Inactivation of p53 rescues the morphological defects and apoptosis in L11-deficient embryos. (A, B) Morphology of L11-
deficient embryos coinjected with either p53 MO or p53 misMO compared to the control embryos at 24 hpf. The overall body length, midbrain-
hindbrain boundary (arrow in A), and enlarged forebrain (asterisk in B) are rescued in p53 MO, but not in p53 misMO-injected L11-deficient embryos.
(C, D) TUNEL staining of p53 MO injected L11-deficient embryos. The numbers of apoptotic cells (TUNEL-positive cells in D) are reduced, almost
similar to those in wild-type embryos, in p53 MO-coinjected embryos compared to rpl11 MO alone–injected embryos. All images are in lateral views
with the anterior to the top in A and D and to the left in B. Scale bars: A, 500 mm; B and D, 200 mm.
doi:10.1371/journal.pone.0004152.g005
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and bind to MDM2, thereby activating p53. To exclude the
possibility of an L5/L23-MDM2 association in L11-deficient
embryos, we simultaneously knocked down the rpl5, rpl11, and
rpl23 genes in zebrafish and analyzed the phenotypes. Our results
showed that even in the absence of these p53 regulatory RPs, the
embryos displayed severe morphological deformities and a high
level of apoptosis, indicating an activated p53 response (Figure S5).
Therefore, it is likely that improper ribosome biogenesis, rather
than the loss of a specific function of L11, activates the p53
dependent response and leads to morphological defects and
increased apoptosis in L11-deficient embryos. Deficiency of any
RP, regardless of its role in p53 regulation, may lead to such a
consequence. RPS19 deficiency in zebrafish was reported to result
in transcriptional activation of p53 [38]. Moreover, a number of
zebrafish lines with mutations in rps8, rps11,a n drps18, identified
through a large scale insertional mutagenesis screen [37], showed
strong upregulation of p53 as well as p53 target genes, including p21
and bax [38]. Rps19 and Rps20 mutations in mice were reported to
cause p53 activation and stabilization leading to pleiotrophic effects
[40]. Haploinsufficiency of the RPs, S6 or L22, induce develop-
mental defects and apoptosis in mice [41,42] and both involve
activation of the p53 checkpoint. In unpublished studies, we also
found that knockdown of rps24 and rpl35 in zebrafish results in
morphological abnormalities and increased apoptosis, indicating an
upregulated p53 response. Thus, an activation of the p53 seems to
be a common response to ribosomal stress.
Upregulation of a truncated isoform of p53, D113p53, which
results from an alternative start site in the 4
th intron and lacks part
of the DNA binding domain [43], was suggested to be a diagnostic
signature of off-target neural death by MOs [36]. Although we
found upregulation of D113p53 transcript in L11-deficient
embryos (data not shown), it was consistent with the data from
other RP mutants [38] and ribosome-associated protein mutants
in zebrafish [39] which reported upregulation of D113p53 isoform.
How does a ribosome biogenesis stress activate the p53
pathway? Previous studies have suggested that mutations in
nucleolar proteins involved in ribosome assembly result in
ribosomal stress and nucleolus disruption resulting in the release
of these three RPs (L5, L11, and L23). These free RPs then bind to
MDM2 and activate p53 [44,45]. However, our data indicates
that even in the absence of these RPs, p53 still gets activated. We
assume that in case of an RP (L11) deficiency, ribosomal subunit
assembly will be severely affected and several nucleolar proteins
that would otherwise participate in the assembly may remain
unutilized. Accumulation of these unused processing factors within
the nucleolus may be sensed as a stress signal leading to an
activated p53 response. Interestingly, we observed upregulation of
bop1, rrs1, and pes, nucleolar proteins required for the nuclear
assembly and export of the 60S pre-ribosomal subunit [24–26,46]
in L11-deficient embryos (data not shown).
However, it still remains unclear why an L11 deficiency results
in restricted phenotypes, mainly in the developing brain, when
ribosomes are so critical and essential for all cells. It has been
suggested that in zebrafish, initial embryonic development relies
on a large pool of maternal ribosomes, and that the brain may be
the first tissue to ‘‘run out’’ of maternal ribosomes [26]. The brain
belongs to the ‘highly proliferative tissue zone’ during early
zebrafish development. During somitogenesis, the rate of ribosome
production may vary between organs and, because of its large size
and rapid development, this rate may be highest in the brain. At
24 hpf, the expression pattern of many assembly factors and
processing proteins, such as bop1, rrs1, and bap28, show a spatial
distribution, with the highest concentration in the brain region
[26,47], supporting the notion that ribosome production is highest
in the brain. Therefore, absence of L11 leads to impaired
ribosome synthesis, which results in phenotypes specific to the
brain region.
As mentioned previously, a number of cellular studies have
shown RPs (L5, L11 and L23) as negative regulator of p53 because
of their MDM2 binding property. A decrease of these RPs should
allow an increase of free MDM2, thereby decreasing the levels of
p53. However, our results indicate that in zebrafish loss of L11
individually or in combination with other two RPs (L5 and L23),
actually increases the p53 activity, rather than decreasing it.
Recently, it has been shown that RP mutant zebrafish which
develop MPNSTs [11], fail to synthesize p53 protein, but this
observed loss of p53 is not due to the L5/L11/L23-MDM2
regulation [48]. Therefore, it seems likely that some other
mechanism of p53 activation exists in the cell which links RPs to
ribosomal biogenesis stress. We speculate that in a model system
like zebrafish, loss of L11 would affect its primary function, namely
participation in ribosome assembly. Accumulation of defective
ribosomes due to RP deficiency would be sensed as a stress signal,
presumably a nucleolar stress, leading to programmed cell death.
A failure to activate this p53-dependent checkpoint could
potentially lead to uncontrolled cell growth, as seen in tumori-
genesis. Such a consequence may be true for other RPs, regardless
of their MDM2-binding properties.
Future studies need to be directed towards understanding the
underlying mechanism of how RP insufficiency activates the p53
pathway and what roles individual RPs play in this pathway. Such
studies could provide valuable insights into the relationship
between ribosomal abnormalities and diseases.
Materials and Methods
Morpholino oligonucleotide injections
Morpholinos were obtained from Gene Tools, LLC (USA). For
rpl11, sequences within 25 bases around the translation start site
(AUG) were used to design the start codon–targeted rpl11
Morpholino (rpl11 MO). For control, an rpl11 mismatch Morpho-
lino (control MO) that included five mispaired bases was used. The
Morpholino sequences are displayed in Table S1. The sequences of
p53 MO and p53 misMO were described by Langheinrich et al [31].
Based on our previous injection experiments [17], rpl11 MO or p53
MO at 0.5 mg/ml( ,50 pg/embryo) were injected into the
blastomere of one-cell stage embryos using an IM-30 Electric
Microinjector (Narishige, Japan). Control MOs were injected at the
same volume as those used for the respective Morpholinos.
Western blot analysis
Embryos (24 hpf) were completely deyolked in Ginzburg Fish
Ringer buffer (55mM NaCl, 1.8mM KCl, 1.25mM NaHCO3) and
washed with PBS. The embryos were collected by centrifugation
and lysed with 2x Laemmli’s buffer for 30 min followed by
centrifugation to remove the debris. After separation in a 12.5%
SDS-PAGE, the proteins were blotted onto a nitrocellulose filter,
hybridized with rabbit polyclonal anti-human L11 antibody
(1:1000), and immunodetected using ECL plus Western Blot
Detection System (GE Healthcare, UK).
TUNEL assay
For detection of apoptotic cells in whole embryos, a TUNEL
assay was performed using an In Situ Cell Death Detection kit-AP
(Roche, Germany) according to a previously described protocol
[49].
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Clones of the in situ markers were obtained from various labs
(mentioned in the Acknowledgement section) and digoxigenin-
labeled antisense RNA probes were generated with T7 or T3
RNA polymerases (Roche) according to the orientation of cDNA
inserts. WISH was performed using the Thisse protocol [50] with
the following modifications: 1) After the proteinase K digestion,
the embryos were soaked in 2 mg/ml glycine-HCl/PBS for 5 min
at room temperature followed by a 4% paraformaldehyde fixation,
2) Prehybridization and hybridization steps were carried out at
65uC, 3) tRNA was added at a concentration of 5 mg/ml to the
hybridization buffer, and 4) The hybridization buffer used in
washing steps contained tRNA and heparin.
In vitro transcription of mRNA
To prepare the MO-resistant rpl11 mRNA, four base changes
were inserted in the Morpholino binding region of rpl11 without
changing the amino acids. The full length cDNA was PCR
amplified with forward and reverse primers containing BamH1
and EcoRI sites, respectively. The double-digested purified PCR
product was then ligated to pCS2+ plasmid (kindly provided by
Dr. K. Inoue, Kobe University, Japan) and capped rpl11 mRNA
was generated from 1 mgo fNot1-linearized pCS2+/rpl11 by SP6
RNA polymerase using the mMESSAGE mMACHINE kit
(Ambion, USA). The synthesized RNA was purified by MEGA-
clear (Ambion). For GFP mRNA, the full length GFP cDNA
inserted clone was digested with NotI followed by in vitro
transcription as mentioned above.
Semi-quantitative RT-PCR
Total RNA was extracted from 25–30 embryos using TRIzol
Reagent (Invitrogen, USA) according to manufacturer’s instruc-
tions. One microgram of total RNA was used as a template in a
20 ml RT-PCR reaction mixture using a one step RT-PCR kit
(Qiagen, Germany). The RT-PCR conditions are as described by
Berghmans et al. [49] except for a change in annealing
temperature, which depended on the Tm value of the primers.
The primers used in this study are listed in Table S2.
Supporting Information
Table S1 The Sequences of Morpholinos Used in This Study
Found at: doi:10.1371/journal.pone.0004152.s001 (0.03 MB
DOC)
Table S2 List of RT-PCR Primers Used in This Study
Found at: doi:10.1371/journal.pone.0004152.s002 (0.04 MB
DOC)
Figure S1 Whole mount in situ hybridization of neural markers
in control MO-injected and wild type embryos.The expression
level and pattern of krox20, shh, and pax6a in control MO-
injected embryos is exactly similar to wild-type embryos at 24 hpf.
All images are in lateral views with anterior to the left. Scale bar:
250 mm
Found at: doi:10.1371/journal.pone.0004152.s003 (6.35 MB TIF)
Figure S2 Time-course expression analysis of p53 and its target
genes. Semi-quantitative RT-PCR of p53, p53 target genes (p21,
mdm2) and apoptotic markers (bax and puma) transcript levels
relative to actin in the morphants and wild-type embryos at 4, 8,
12, and 48 hpf.
Found at: doi:10.1371/journal.pone.0004152.s004 (0.58 MB TIF)
Figure S3 Inhibition of p53 activity and suppression of apoptosis
by p53 MO. Zebrafish embryos at the one-cell stage were injected
with p53 MO and p53 misMO at 50 pg/embryo. At 24 hpf, the
embryos were exposed to 400 mJ/cm UV light for 5 s. Six hours
later, they were fixed for TUNEL staining and RT-PCR. (A)
Semiquantitative RT-PCR of p53-target genes in UV-exposed
embryos injected with p53 MO (50 pg/embryo) or p53 misMO
(50 pg/embryo). The p53 response genes are completely down-
regulated in p53 MO-injected, but not in p53 misMO-injected,
embryos. (B–E) TUNEL staining of p53 MO- and p53 misMO-
injected embryos before and after UV exposure. The embryos
injected with p53 MO show a complete inhibition of apoptosis
(indicated by an absence of TUNEL-positive cells) after UV
exposure, whereas p53 misMO-injected embryos show extensive
apoptosis. All images are in lateral view with anterior to the left.
Scale bar: 500 mm.
Found at: doi:10.1371/journal.pone.0004152.s005 (3.42 MB TIF)
Figure S4 Phenotype of L11morphants at 2 day post fertilization
(dpf). Morphology of L11 morphants (upper panel) shows slightly
smaller head and eyes, round grey yolk with thin extension,
identical to that observed in L11 mutant (rpl11hi3820btg). Lower
panel is the wild-type embryo at day 2 dpf. All images are in lateral
views with anterior to the left. Scale bar: 1mm
Found at: doi:10.1371/journal.pone.0004152.s006 (7.92 MB TIF)
Figure S5 Morphological observation and TUNEL staining of
embryos injected simultaneously with rpl5, rpl11, and rpl23
MOs.(A) Lateral views of 24 hpf embryos simultaneously injected
with the three MOs. Severe morphological deformities with almost
a complete absence of brain subdivisions (black arc) were observed
in the morphants. (B) Dorsal and lateral views of the head region
of 24 hpf embryos showing extensive apoptosis (blue dots). Scale
bars: A, 250 mm; B, 100 mm.
Found at: doi:10.1371/journal.pone.0004152.s007 (8.39 MB TIF)
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